newsfilter
← Latest News
PR Newswire·

Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral Infections

ARDS-003 is a novel therapeutic for acute systemic inflammation and prevention of acute respiratory distress syndrome (ARDS). ARDS-003 may offer steroid-sparing opportunities. ARDS-003 has demonstrated antiviral properties. ARDS-003 developed as an o